GC Cell Corp
KOSDAQ:144510
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
GC Cell Corp
Depreciation & Amortization
GC Cell Corp
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
GC Cell Corp
KOSDAQ:144510
|
Depreciation & Amortization
-₩2.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
-108%
|
CAGR 10-Years
-38%
|
|
|
Celltrion Inc
KRX:068270
|
Depreciation & Amortization
-₩70.8B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-22%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Depreciation & Amortization
-₩2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Depreciation & Amortization
-₩3.6B
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
-62%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Depreciation & Amortization
-₩3.4B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Depreciation & Amortization
-₩5.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GC Cell Corp
Glance View
GC Cell Corp. engages in the research and development of cell curing agents and in the transport and sale of consignment inspection samples. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2016-06-23. The firm operates its business through four segments. The Specimen Testing Service segment provides sample testing services, clinical trial services, and veterinary testing services. The Cell Therapy segment is engaged in cell culture and technology transfer business. The Cord Blood Storage segment is engaged in the cord blood storage business. The Other Business segment is engaged in bio-logistics business and others.
See Also
What is GC Cell Corp's Depreciation & Amortization?
Depreciation & Amortization
-2.8B
KRW
Based on the financial report for Dec 31, 2025, GC Cell Corp's Depreciation & Amortization amounts to -2.8B KRW.
What is GC Cell Corp's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-38%
Over the last year, the Depreciation & Amortization growth was 11%. The average annual Depreciation & Amortization growth rates for GC Cell Corp have been 13% over the past three years , -108% over the past five years , and -38% over the past ten years .
